MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $514,000 | -77.3% | 11,900 | -82.1% | 0.01% | -84.0% |
| Q4 2014 | $2,262,000 | -54.9% | 66,400 | -49.0% | 0.08% | -57.1% |
| Q3 2014 | $5,018,000 | +1.1% | 130,100 | +2.0% | 0.19% | -16.4% |
| Q2 2014 | $4,962,000 | +475.6% | 127,500 | +406.0% | 0.23% | +402.2% |
| Q1 2014 | $862,000 | -83.1% | 25,200 | -88.4% | 0.04% | -90.2% |
| Q3 2013 | $5,088,000 | – | 216,500 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |